Cargando…
Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone anal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290672/ https://www.ncbi.nlm.nih.gov/pubmed/25628605 http://dx.doi.org/10.3389/fendo.2014.00240 |
_version_ | 1782352283747483648 |
---|---|
author | Davis, Paul J. Glinsky, Gennadi V. Lin, Hung-Yun Leith, John T. Hercbergs, Aleck Tang, Heng-Yuan Ashur-Fabian, Osnat Incerpi, Sandra Mousa, Shaker A. |
author_facet | Davis, Paul J. Glinsky, Gennadi V. Lin, Hung-Yun Leith, John T. Hercbergs, Aleck Tang, Heng-Yuan Ashur-Fabian, Osnat Incerpi, Sandra Mousa, Shaker A. |
author_sort | Davis, Paul J. |
collection | PubMed |
description | Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone analogs. From this receptor, thyroid hormone (l-thyroxine, T(4); 3,5,3′-triiodo-l-thyronine, T(3)) and tetraiodothyroacetic acid (tetrac) regulate expression of specific genes by a mechanism that is initiated non-genomically. At the integrin, T(4) and T(3) at physiological concentrations are pro-angiogenic by multiple mechanisms that include gene expression, and T(4) supports tumor cell proliferation. Tetrac blocks the transcriptional activities directed by T(4) and T(3) at αvβ3, but, independently of T(4) and T(3), tetrac modulates transcription of cancer cell genes that are important to cell survival pathways, control of the cell cycle, angiogenesis, apoptosis, cell export of chemotherapeutic agents, and repair of double-strand DNA breaks. We have covalently bound tetrac to a 200 nm biodegradable nanoparticle that prohibits cell entry of tetrac and limits its action to the hormone receptor on the extracellular domain of plasma membrane αvβ3. This reformulation has greater potency than unmodified tetrac at the integrin and affects a broader range of cancer-relevant genes. In addition to these actions on intra-cellular kinase-mediated regulation of gene expression, hormone analogs at αvβ3 have additional effects on intra-cellular protein-trafficking (cytosol compartment to nucleus), nucleoprotein phosphorylation, and generation of nuclear coactivator complexes that are relevant to traditional genomic actions of T(3). Thus, previously unrecognized cell surface-initiated actions of thyroid hormone and tetrac formulations at αvβ3 offer opportunities to regulate angiogenesis and multiple aspects of cancer cell behavior. |
format | Online Article Text |
id | pubmed-4290672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42906722015-01-27 Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac Davis, Paul J. Glinsky, Gennadi V. Lin, Hung-Yun Leith, John T. Hercbergs, Aleck Tang, Heng-Yuan Ashur-Fabian, Osnat Incerpi, Sandra Mousa, Shaker A. Front Endocrinol (Lausanne) Endocrinology Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone analogs. From this receptor, thyroid hormone (l-thyroxine, T(4); 3,5,3′-triiodo-l-thyronine, T(3)) and tetraiodothyroacetic acid (tetrac) regulate expression of specific genes by a mechanism that is initiated non-genomically. At the integrin, T(4) and T(3) at physiological concentrations are pro-angiogenic by multiple mechanisms that include gene expression, and T(4) supports tumor cell proliferation. Tetrac blocks the transcriptional activities directed by T(4) and T(3) at αvβ3, but, independently of T(4) and T(3), tetrac modulates transcription of cancer cell genes that are important to cell survival pathways, control of the cell cycle, angiogenesis, apoptosis, cell export of chemotherapeutic agents, and repair of double-strand DNA breaks. We have covalently bound tetrac to a 200 nm biodegradable nanoparticle that prohibits cell entry of tetrac and limits its action to the hormone receptor on the extracellular domain of plasma membrane αvβ3. This reformulation has greater potency than unmodified tetrac at the integrin and affects a broader range of cancer-relevant genes. In addition to these actions on intra-cellular kinase-mediated regulation of gene expression, hormone analogs at αvβ3 have additional effects on intra-cellular protein-trafficking (cytosol compartment to nucleus), nucleoprotein phosphorylation, and generation of nuclear coactivator complexes that are relevant to traditional genomic actions of T(3). Thus, previously unrecognized cell surface-initiated actions of thyroid hormone and tetrac formulations at αvβ3 offer opportunities to regulate angiogenesis and multiple aspects of cancer cell behavior. Frontiers Media S.A. 2015-01-12 /pmc/articles/PMC4290672/ /pubmed/25628605 http://dx.doi.org/10.3389/fendo.2014.00240 Text en Copyright © 2015 Davis, Glinsky, Lin, Leith, Hercbergs, Tang, Ashur-Fabian, Incerpi and Mousa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Davis, Paul J. Glinsky, Gennadi V. Lin, Hung-Yun Leith, John T. Hercbergs, Aleck Tang, Heng-Yuan Ashur-Fabian, Osnat Incerpi, Sandra Mousa, Shaker A. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title | Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title_full | Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title_fullStr | Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title_full_unstemmed | Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title_short | Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac |
title_sort | cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290672/ https://www.ncbi.nlm.nih.gov/pubmed/25628605 http://dx.doi.org/10.3389/fendo.2014.00240 |
work_keys_str_mv | AT davispaulj cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT glinskygennadiv cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT linhungyun cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT leithjohnt cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT hercbergsaleck cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT tanghengyuan cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT ashurfabianosnat cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT incerpisandra cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac AT mousashakera cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac |